Who
Edgardo Hernandez
EVP & Pres., Mfg. Operations
Company insider
Files Form 4 as: EVP & Pres., Mfg. Operations, Eli Lilly and.
In numbers
- Trades disclosed
- 29
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Feb 2022
- Last trade
- 2 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Sep 2026filed 4 Sep 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code G | —13 at $0.00 | filing |
| 2 Sep 2026filed 4 Sep 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code G | —13 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $4.6M4,383.734 at $1,044.67 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $4.6M4,383.73 at $1,044.67 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —3,572 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $1.7M1,591.452 at $1,037.15 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —3,572 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —3,572 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —3,572 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $1.7M1,591.45 at $1,037.15 | filing |
| 5 Sep 2025filed 8 Sep 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code G | —17 at $0.00 | filing |
| 1 Mar 2025filed 3 Mar 2025 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,837 at $0.00 | filing |
| 1 Mar 2025filed 3 Mar 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —2,837 at $0.00 | filing |
| 1 Mar 2025filed 3 Mar 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $1.2M1,260.33 at $920.63 | filing |
| 10 Feb 2025filed 12 Feb 2025 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —3,572 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $5.2M5,974.14 at $868.88 | filing |
| 1 Feb 2025filed 4 Feb 2025 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,861 at $0.00 | filing |
| 1 Feb 2025filed 4 Feb 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —2,861 at $0.00 | filing |
| 1 Feb 2025filed 4 Feb 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $1.0M1,281.58 at $811.08 | filing |
| 1 Nov 2024filed 5 Nov 2024 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,687 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.